Emerging Markets
SESSION 8. Emerging Markets
As global pharmaceutical markets expand, emerging economies present both significant opportunities and challenges. This session will scrutinise growth strategies for entering these markets, focusing on the unique regulatory landscapes and the need to adapt drug development processes. Strategic partnerships and the rising demand for biologics in emerging regions will also be highlighted.
Sub-Sessions:
Track 8-1 Pharma Market Entry Strategies
Track 8-2 Regulatory Landscape in Emerging Economies
Track 8-3 Adapting Drug Development for Emerging Markets
Track 8-4 Strategic Partnerships in Emerging Markets
Track 8-5 Market Demand for Biologics in Emerging Regions